Is a complete TSXV/NTLX research report available?

No complete published report is available for tsxv/NTLX (TSXV/NTLX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/NTLX (TSXV/NTLX)

TSX Venture Exchange: TSXV/NTLX · CAD

CA$1.62

+0.00 (0.0%)· Recorded snapshot

Market cap	22.2M
Revenue (ttm)	965.7K
Net income (ttm)	-7.4M
EPS (ttm)	-CA$1.25
Shares out	13.7M
Volume	0
Beta	-0.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 965.7K
Net income (ttm): -7.4M
EPS (ttm): -CA$1.25
Market cap: 22.2M

All TSXV/NTLX indicators

Market & fundamental data

Available fields

132

Groups with data

Currency

USD

Showing 132 of 132 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-12-01
Enterprise value	CAD 28.3M
Exchange	TSX Venture Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Industry	Drug Manufacturers - General
Is primary listing	Yes
ISIN number	CA64136J2002
Last refreshed	2026-10-28
Last stock split date	2026-09-02
Last stock split type	Reverse
Market cap	CAD 22.2M
Next earnings date	2026-12-01
Price	CAD 1.62
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	tsxv/NTLX
Website	https://www.neurothera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-77.23%
EV/Sales	29.34x
P/B ratio	2.11x
P/S ratio	23.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	71.18%
Operating margin	-565.44%
Pretax margin	-795.29%
ROCE	-45.67%
SBC / revenue	138.09%
Tax / revenue	2.79%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-4.35%
Gross profit growth (Q)	-40.83%
Revenue growth	-47.93%
Revenue growth (Q)	-38.18%
Revenue growth (QoQ)	0%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 256,935
EBIT	CAD -5.5M
EBITDA	CAD -5.2M
EPS	CAD -1.25
Financing cash flow	CAD 2.3M
Gross profit	CAD 687,328
Income taxes	CAD 26,982
Investing cash flow	CAD 1.2M
Net borrowing	CAD 1.6M
Net cash flow	CAD 1.2M
Net income	CAD -7.4M
Operating cash flow minus SBC	CAD -3.6M
Operating income	CAD -5.5M
Revenue	CAD 965,668
Stock-based compensation	CAD 1.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.82
Book value per share	CAD 0.43
Debt / equity	0.12
Interest coverage	-22.49
Long-term assets	CAD 16.2M
Long-term liabilities	CAD 1.5M
Net cash (debt)	CAD -9,941
Net cash / market cap	-0.04%
Net debt / equity	0
Piotroski F-Score	2
Shareholders' equity	CAD 10.5M
Tangible book value	CAD -11.8M
Tangible book value per share	CAD -1.14
Total assets	CAD 17.6M
Total cash	CAD 1.3M
Total debt	CAD 1.3M
Total liabilities	CAD 7.1M
WACC	4.72%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 1.4M
Current liabilities	CAD 5.6M
Current ratio	0.25
Net working capital	CAD -5M
Quick ratio	0.23
Working capital	CAD -4.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-30.61%
Shareholder yield	-30.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	0%
1M price change	-63.18%
1M total return	-63.18%
1W price change	-2.99%
1W total return	-2.99%
20-day SMA	CAD 3.54
3M price change	-31.93%
3M total return	-31.93%
3Y price change	-25.35%
3Y return CAGR	-9.28%
3Y total return	-25.35%
50-day SMA	CAD 2.95
52-week high	CAD 5.32
52-week high date	2026-08-25
52-week low	CAD 1.61
52-week low date	2026-10-22
5Y price change	-29.87%
5Y return CAGR	-6.85%
5Y total return	-29.87%
6M price change	-27.68%
6M total return	-27.68%
All-time high	CAD 5.32
All-time high date	2026-08-25
All-time low	CAD 1.61
All-time low date	2026-10-22
Average true range (ATR)	CAD 0.44
Average volume	2.1K
Beta (1Y)	-0.78
Beta (2Y)	-0.41
Beta (5Y)	-0.02
Change from 52-week high	-69.55%
Change from 52-week low	0.62%
Change from all-time high	-69.55%
Change from all-time low	0.62%
Monthly RSI	44.55
Previous close	CAD 1.62
Price vs 20-day SMA	-54.26%
Price vs 50-day SMA	-45.16%
Relative volume	0.17
RSI	36.58
Sharpe ratio	1.22
Sortino ratio	2.27
Volume	0
Weekly RSI	44
YTD price change	-31.93%
YTD total return	-31.93%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7.5M
Shares change (QoQ)	0%
Shares change (YoY)	30.61%
Shares held by insiders	0.39%
Shares outstanding	13.7M

tsxv/NTLX stock profile | StockMarketAgent.AI

TSXV/NTLX (TSXV/NTLX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/NTLX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/NTLX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/NTLX

Frequently asked questions